Clinical impact of PD-L1 and PD-1 expression in squamous cell cancer of the vulva

被引：0
|
作者：
Fabinshy Thangarajah
Bernd Morgenstern
Caroline Pahmeyer
Lars Mortimer Schiffmann
Julian Puppe
Peter Mallmann
Stefanie Hamacher
Reinhard Buettner
Christina Alidousty
Barbara Holz
Andreas H. Scheel
Anne Maria Schultheis
机构：
[1] University of Cologne,Department of Obstetrics and Gynaecology, Medical Faculty, University Hospital Cologne
[2] University of Cologne,Department of General, Visceral and Cancer Surgery
[3] University Hospital Cologne,Institute of Medical Statistics and Computational Biology
[4] Institute of Pathology,Department of Pathology, University Hospital of Cologne
来源：
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词：
Vulvar carcinoma; PD-L1; PD-1; HPV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1651 / 1660
页数：9
相关论文
共 50 条
  • [41] PD-1/PD-L1 and immunotherapy for pancreatic cancer
    Feng, Mengyu
    Xiong, Guangbing
    Cao, Zhe
    Yang, Gang
    Zheng, Suli
    Song, Xujun
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    CANCER LETTERS, 2017, 407 : 57 - 65
  • [42] The Clinical Significance of PD-L1/PD-1 Expression in Gastroenteropancreatic Neuroendocrine Neoplasia
    Wang, Chuying
    Yu, Jiao
    Fan, Yangwei
    Ma, Ke
    Ning, Jing
    Hu, Yuan
    Niu, Wenxia
    Dong, Xuyuan
    Wu, Yinying
    Li, Enxiao
    Dong, Danfeng
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2019, 49 (04): : 448 - 456
  • [43] Expression of PD-1/PD-L1 in lung adenocarcinoma and its clinical significance
    Jian Li
    Yimin Chen
    Oncology and Translational Medicine, 2021, 7 (01) : 15 - 19
  • [44] PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome
    Schneider, Sven
    Kadletz, Lorenz
    Wiebringhaus, Robert
    Kenner, Lukas
    Selzer, Edgar
    Fuereder, Thorsten
    Rajky, Orsolya
    Berghoff, Anna S.
    Preusser, Matthias
    Heiduschka, Gregor
    HISTOPATHOLOGY, 2018, 73 (04) : 573 - 584
  • [45] The role of the PD-L1: PD-1 pathway in squamous cell carcinoma of the head and neck
    Zandberg, Dan P.
    Strome, Scott E.
    ORAL ONCOLOGY, 2014, 50 (07) : 627 - 632
  • [46] Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
    Koh, Young wha
    Han, Jae-ho
    Haam, Seokjin
    Lee, Hyun woo
    ANTICANCER RESEARCH, 2024, 44 (05) : 2081 - 2089
  • [47] Keratoacanthoma and Cutaneous Squamous Cell Carcinoma With PD-1 and PD-L1 Inhibitor Use
    Aggarwal, Pushkar
    Clark, Denise
    Shah, Aatman
    Rismiller, Kyle
    Neltner, Scott A.
    JAMA DERMATOLOGY, 2024, 160 (05) : 573 - 575
  • [48] PD-1 and PD-L1 Expression in Endometrial Cancer: A Systematic Review of the Literature
    Tommasi, Orazio De
    Marchetti, Matteo
    Tripepi, Marta
    Bigardi, Sofia
    Incognito, Giosue Giordano
    Tuninetti, Valentina
    Facchetti, Emma
    Tasca, Giulia
    Noventa, Marco
    Saccardi, Carlo
    Tozzi, Roberto
    Spagnol, Giulia
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [49] PD-L1 and PD-1 Expression in Pediatric Intracranial Germ Cell Tumors
    Woods, Jared
    Lidov, Hart
    Ligon, Keith
    Santagata, Sandro
    Warren, Katherine
    Chi, Susan
    Yeo, Kee
    Alexandrescu, Sanda
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 589 - 589
  • [50] PD-1/PD-L1 Expression in Brain Metastases from Breast Cancer
    Gawelek, Kara
    Williams, Nicole
    Varadan, Vinay
    Harris, Lyndsay
    Gilmore, Hannah
    LABORATORY INVESTIGATION, 2016, 96 : 42A - 42A
12345